Cite

    Gagelmann, N., Salit, R. B., Schroeder, T., Badbaran, A., Rautenberg, C., Panagiota, V., Wolschke, C., Thol, F., Cassinat, B., Robin, M., Heuser, M., Reinhardt, H. C., Scott, B. L., & Kröger, N. (2022). high Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative Analysis. HemaSphere, 6(10), e784–. http://access.bl.uk/ark:/81055/vdc_100179397662.0x00000a